[go: up one dir, main page]

UA90656C2 - Gaboxadol for treating depression - Google Patents

Gaboxadol for treating depression

Info

Publication number
UA90656C2
UA90656C2 UAA200600374A UAA200600374A UA90656C2 UA 90656 C2 UA90656 C2 UA 90656C2 UA A200600374 A UAA200600374 A UA A200600374A UA A200600374 A UAA200600374 A UA A200600374A UA 90656 C2 UA90656 C2 UA 90656C2
Authority
UA
Ukraine
Prior art keywords
gaboxadol
treating depression
pharmaceutical composition
relates
serotonin
Prior art date
Application number
UAA200600374A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Конни Санчес
Бьярке Эберт
Original Assignee
Х. Луннбек А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36701616&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA90656(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Луннбек А/С filed Critical Х. Луннбек А/С
Publication of UA90656C2 publication Critical patent/UA90656C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to use of gaboxadol for preparing a pharmaceutical composition for treating depression. Moreover, it relates to the use of gaboxadol for the preparation of a pharmaceutical composition to be used in combination with a serotonin reuptake inhibitor or any other compound, which causes an elevation in the level of extracellular serotonin.
UAA200600374A 2003-06-25 2004-06-25 Gaboxadol for treating depression UA90656C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200300956 2003-06-25

Publications (1)

Publication Number Publication Date
UA90656C2 true UA90656C2 (en) 2010-05-25

Family

ID=36701616

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200600374A UA90656C2 (en) 2003-06-25 2004-06-25 Gaboxadol for treating depression

Country Status (4)

Country Link
CN (2) CN101156850A (en)
CL (1) CL2004001603A1 (en)
UA (1) UA90656C2 (en)
ZA (1) ZA200509356B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123332B2 (en) 2018-11-21 2021-09-21 Certego Therapeutics Inc. Gaboxadol for reducing risk of suicide and rapid relief of depression
US11597726B2 (en) 2020-05-20 2023-03-07 Certego Therapeutics Inc. Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105816457A (en) * 2016-05-30 2016-08-03 杨强 Pharmaceutical composition containing paroxetine hydrochloride and application of pharmaceutical composition
US20180338959A1 (en) * 2017-05-24 2018-11-29 Ovid Therapeutics Inc. Treatment of depressive disorders
CA3095682A1 (en) * 2018-04-06 2019-10-10 Ovid Therapeutics Inc. Use of gaboxadol in the treatment of substance use disorders

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123332B2 (en) 2018-11-21 2021-09-21 Certego Therapeutics Inc. Gaboxadol for reducing risk of suicide and rapid relief of depression
US11597726B2 (en) 2020-05-20 2023-03-07 Certego Therapeutics Inc. Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Also Published As

Publication number Publication date
CL2004001603A1 (en) 2005-05-27
ZA200509356B (en) 2007-03-28
CN101156850A (en) 2008-04-09
CN1809350A (en) 2006-07-26

Similar Documents

Publication Publication Date Title
IL202106A0 (en) Gaboxadol for treating depression and other affective disorders
MY153915A (en) Organic compounds
UA103319C2 (en) Thiazole- and oxazole-benzene sulfonamide compounds
PT1984357E (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
MX2009005455A (en) (r)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs.
WO2008021851A3 (en) Novel compounds as antagonists or inverse agonists for opioid receptors
TW201713640A (en) Bruton's tyrosine kinase inhibitors
CY1109916T1 (en) Benzimidazolo-thiophene compounds as PLK inhibitors
MX2007008790A (en) Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use.
TW200740799A (en) Alpha2C adrenoreceptor agonists
MA32776B1 (en) INHIBITORS OF AKT AND P70 S6 KINASE
WO2008034142A3 (en) Synthesis, methods of using, and compositions of cycloalkylmethylamines
TW200942524A (en) Novel aminomethyl benzene derivatives
BRPI0912229A2 (en) oxygen removal mixture, composition, article, standard mixture, and use of a mixture
CL2008003231A1 (en) Substituted 1,3-dihydro-5-isobenzofurancarbonitrile derivative compounds, selective serotonin reuptake inhibitors; pharmaceutical composition; preparation procedure; Useful in the treatment and / or prevention of premature ejaculation.
TW200736227A (en) New compounds III
WO2010023473A3 (en) Crystalline form of sunitinib and processes for its preparation
TW200700071A (en) Novel use
TNSN07241A1 (en) Substituted pyrroles, compositions containing same, method for making same and use thereof
MX2007006042A (en) Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof.
UA90656C2 (en) Gaboxadol for treating depression
WO2009158387A3 (en) Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption
MEP1908A (en) Gaboxadol for treating depression and other affective disorders
WO2007121883A3 (en) 1,4:3,6-dianhydromannitol derivatives and use thereof
TW200706173A (en) Oral composition comprising carbamylating agent